Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03775837

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults: a Randomized, Double-blinded, Placebo-controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Pusan National University Yangsan Hospital · Academic / Other
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Accepted

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.

Detailed description

Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Panax Ginseng C.A. Mey Extract on liver function in adults; the safety of the compound are also evaluate. The Investigators examine AST, ALT, GGT, and other metabolic parameters at baseline, as well as after 4 and 8 weeks of intervention. Sixty adults were administered either 600 mg of Panax Ginseng C.A. Mey Extract or a placebo each day for 8 weeks;

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPanax Ginseng C.A. Mey Extract groupThis group takes Panax Ginseng C.A. Mey Extract for 8 weeks
DIETARY_SUPPLEMENTPlacebo groupThis group takes placebo for 8 weeks

Timeline

Start date
2018-12-01
Primary completion
2025-12-30
Completion
2025-12-31
First posted
2018-12-14
Last updated
2025-06-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03775837. Inclusion in this directory is not an endorsement.